Mainstream

GSK falls as FDA advisors vote against approving blood cancer drug

GSK falls as FDA advisors vote against approving blood cancer drug

Post ContentgskRead More

You might also be interested in reading Nasdaq, S&P, Dow futures steady after Wall Street notches new record highs.

July 17, 2025
In Mainstream